LAUREN MERCER: Open Payments
NPI 1922261874 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 24 payments from 7 companies in 2025. Trend: 2023 $754 · 2024 $705 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $151 |
| Lundbeck LLC | 6 | $144 |
| Neurocrine BioSciences, Inc. | 4 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| ABBVIE INC. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: REXULTI, AUSTEDO XR, INGREZZA, TRINTELLIX, VRAYLAR, Auvelity.
Industry payments across CT — which companies pay providers there.
